Method and system for acquiring spectral data for use in assessing risk of breast cancer

A system for enabling a determination of the risk of developing breast cancer of a subject, comprising:

• a. a magnetic resonance spectroscopy device to obtain the level of the spectral signal at 3.15 and 3.19 ppm, within the breast tissue of the subject, and
• b. a comparator for comparing the level of the spectral signal obtained in step a. with a reference level of a spectral signal at 3.15 and 3.19 ppm from the breast of a healthy subject, to determine whether the level of the signal obtained in step a. exceeds the reference level of a healthy subject, is comparable to that of a subject known to be at elevated risk, or is elevated to the level of persons known to be carrying a gene mutation.

A system for enabling a determination of the risk of developing breast cancer of a subject, comprising:

• a. a processor for processing spectral data obtained from the breast tissue of the subject using a magnetic resonance spectroscopy device to obtain the level of the spectral signal at 3.15 and 3.19 ppm, and
• b. a comparator for comparing the level of the spectral signal obtained in step a. with a reference level of a spectral signal at 3.15 and 3.19 ppm from the breast of a healthy subject, to determine whether the level of the signal obtained in step a. exceeds the reference level of a healthy subject, is comparable to that of a subject known to be at elevated risk, or is elevated to the level of persons known to be carrying a gene mutation.